Business Today
The United States has delivered a massive vote of confidence in India’s pharmaceutical sector. Speaking on India-U.S. healthcare and trade ties, U.S. officials highlighted that nearly 40% of America’s generic medicines are imported from India because of the deep trust in Indian pharma companies. The U.S. also revealed that India alone announced over $20.5 billion in investments for the coming year, with nearly $19 billion linked to pharmaceuticals. The partnership now goes beyond trade, focusing on securing global supply chains, preventing medicine shortages, and boosting healthcare innovation. India and the U.S. are also strengthening biomedical research collaborations, including cancer treatment technology and health-tech partnerships. The growing alliance signals a major opportunity for Indian pharma companies, investors, exports, and long-term healthcare cooperation between the two countries.
Go to News Site